See also this year's filing and all EDGAR filings for this company.
PDF Report 0001404644_2019_Neoleukin_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001404644, Neoleukin Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 77,165,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 400,000 |
| 3 | remainder_Assets | 53,000 |
| 4 | LiabilitiesCurrent | 4,627,000 |
| 5 | LiabilitiesNoncurrent | 319,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,835,000 |
| 9 | ResearchAndDevelopmentExpense | 41,789,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 25,000,000 |
| 12 | remainder_NetIncome | 1,039,000 |
| 13 | remainder_ComprehensiveNetIncome | 70,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 77,618,000 |
| 1 | Liabilities | 4,946,000 |
| 2 | Expenses | 57,624,000 |
| 3 | Revenues | 25,000,000 |
| 4 | StockholdersEquity | 72,672,000 |
| 5 | NetIncome | -31,585,000 |
| 6 | ComprehensiveNetIncome | -31,550,000 |
| 7 | BaseVar | 83,148,500 |
| 8 | EconomicCapitalRatio | 2.26 |
Edgar->Model Mapping
Feature Distribution
Change over Time
